Braeburn INC Formerly Known as Braeburn Pharmaceuticals INC

Based in PA

🤖

AI Overview

With $1.9M in lobbying spend across 17 quarterly filings, Braeburn INC Formerly Known as Braeburn Pharmaceuticals INC is a significant lobbying presence. Their lobbying covers 5 issue areas. Active from 2018 to 2021.

$1.9M
Total Spend
4
Years Active
1
Firms Hired
1
Lobbyists Deployed
5
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$400K
2019$600K
2020$420K
2021$480K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Braeburn INC Formerly Known as Braeburn Pharmaceuticals INC disclosed contacting in their lobbying filings.

Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESOffice of Natl Drug Control Policy (NDCP)SENATESubstance Abuse & Mental Health Services Administration (SAMHSA)Drug Enforcement Administration (DEA)Justice, Dept of (DOJ)White House Office
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Alcohol & Drug Abuse, Health Issues, Medicare/Medicaid, Pharmacy, Insurance

HR 5202 - Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 , S. 916 - Protecting Patient Access to Emergency Medications Act of 2017: To amend the Controlled Substances Act to

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.